LEADER 03673nam 2200697 450 001 9910794334103321 005 20201204082343.0 010 $a1-4704-6253-2 035 $a(CKB)4100000011437433 035 $a(MiAaPQ)EBC6346635 035 $a(RPAM)21697713 035 $a(PPN)250799235 035 $a(EXLCZ)994100000011437433 100 $a20201204d2020 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aExplicit arithmetic of Jacobians of generalized Legendre curves over global function fields /$fLisa Berger [and seven others] 210 1$aProvidence, Rhode Island :$cAmerican Mathematical Society,$d[2020] 210 4$dİ2020 215 $a1 online resource (144 pages) 225 1 $aMemoirs of the American Mathematical Society ;$vNumber 1295 300 $a"Forthcoming, volume 266, number 1295." 311 $a1-4704-4219-1 320 $aIncludes bibliographical references. 327 $aThe curve, explicit divisors, and relations -- Descent calculations -- Minimal regular model, local invariants, and domination by a product of curves -- Heights and the visible subgroup -- The L-function and the BSD conjecture -- Analysis of J[p] and NS(Xd)tor -- Index of the visible subgroup and the Tate-Shafarevich group -- Monodromy of ?-torsion and decomposition of the Jacobian. 330 $a"We study the Jacobian J of the smooth projective curve C of genus r-1 with affine model yr = xr-1(x+ 1)(x + t) over the function field Fp(t), when p is prime and r [greater than or equal to] 2 is an integer prime to p. When q is a power of p and d is a positive integer, we compute the L-function of J over Fq(t1/d) and show that the Birch and Swinnerton-Dyer conjecture holds for J over Fq(t1/d). When d is divisible by r and of the form p[nu] + 1, and Kd := Fp([mu]d, t1/d), we write down explicit points in J(Kd), show that they generate a subgroup V of rank (r-1)(d-2) whose index in J(Kd) is finite and a power of p, and show that the order of the Tate-Shafarevich group of J over Kd is [J(Kd) : V ]2. When r > 2, we prove that the "new" part of J is isogenous over Fp(t) to the square of a simple abelian variety of dimension [phi](r)/2 with endomorphism algebra Z[[mu]r]+. For a prime with pr, we prove that J[](L) = {0} for any abelian extension L of Fp(t)"--$cProvided by publisher. 410 0$aMemoirs of the American Mathematical Society ;$vNumber 1295. 606 $aCurves, Algebraic 606 $aLegendre's functions 606 $aRational points (Geometry) 606 $aBirch-Swinnerton-Dyer conjecture 606 $aJacobians 606 $aAbelian varieties 606 $aFinite fields (Algebra) 615 0$aCurves, Algebraic. 615 0$aLegendre's functions. 615 0$aRational points (Geometry) 615 0$aBirch-Swinnerton-Dyer conjecture. 615 0$aJacobians. 615 0$aAbelian varieties. 615 0$aFinite fields (Algebra) 676 $a516.352 686 $a11G10$a11G30$a11G40$a14G05$a14G25$a14K15$2msc 700 $aBerger$b Lisa$f1969-$01539873 702 $aHall$b Chris$f1975- 702 $aPannekoek$b Rene? 702 $aPark$b Jennifer Mun Young 702 $aPries$b Rachel$f1972- 702 $aSharif$b Shahed$f1977- 702 $aSilverberg$b Alice 702 $aUlmer$b Douglas$f1960- 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910794334103321 996 $aExplicit arithmetic of Jacobians of generalized Legendre curves over global function fields$93791043 997 $aUNINA LEADER 02278nam 2200673 450 001 9910789154403321 005 20230126211806.0 010 $a0-268-07594-8 035 $a(CKB)3710000000080963 035 $a(EBL)3441154 035 $a(SSID)ssj0001256426 035 $a(PQKBManifestationID)11700148 035 $a(PQKBTitleCode)TC0001256426 035 $a(PQKBWorkID)11258949 035 $a(PQKB)10808586 035 $a(MiAaPQ)EBC3441154 035 $a(OCoLC)869434652 035 $a(MdBmJHUP)muse31459 035 $a(Au-PeEL)EBL3441154 035 $a(CaPaEBR)ebr10821821 035 $a(EXLCZ)993710000000080963 100 $a20130812h20132013 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aWriting faith and telling tales $eliterature, politics, and religion in the work of Thomas More /$fThomas Betteridge 210 1$aNotre Dame, Indiana :$cUniversity of Notre Dame Press,$d[2013] 210 4$dİ2013 215 $a1 online resource (272 p.) 225 1 $aReFormations : medieval and early modern 300 $aDescription based upon print version of record. 311 $a0-268-02239-9 320 $aIncludes bibliographical references and index. 327 $aPolitics -- Reason -- Heresy -- Devotion. 410 0$aReformations. 606 $aReformation$zEngland$xHistoriography 606 $aChristian literature, Latin (Medieval and modern)$zEngland$xHistory and criticism 606 $aReligious thought$y16th century 606 $aPhilosophy, Medieval 606 $aHumanism$zEngland$xHistory$y16th century 607 $aGreat Britain$xHistory$yHenry VIII, 1509-1547 607 $aEngland$xIntellectual life$y16th century 615 0$aReformation$xHistoriography. 615 0$aChristian literature, Latin (Medieval and modern)$xHistory and criticism. 615 0$aReligious thought 615 0$aPhilosophy, Medieval. 615 0$aHumanism$xHistory 676 $a942.052092 676 $aB 700 $aBetteridge$b Thomas$0863723 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910789154403321 996 $aWriting faith and telling tales$93850637 997 $aUNINA LEADER 03966nam 2200709 a 450 001 9910818860903321 005 20240516065005.0 010 $a9786613694232 010 $a9780470720578 010 $a0470720573 010 $a9781280783845 010 $a1280783842 010 $a9780470718254 010 $a0470718250 035 $a(CKB)1000000000688126 035 $a(StDuBDS)AH13351468 035 $a(SSID)ssj0000715465 035 $a(PQKBManifestationID)11434947 035 $a(PQKBTitleCode)TC0000715465 035 $a(PQKBWorkID)10703791 035 $a(PQKB)10390856 035 $a(MiAaPQ)EBC703896 035 $a(Au-PeEL)EBL703896 035 $a(CaPaEBR)ebr10575660 035 $a(CaONFJC)MIL369423 035 $a(OCoLC)797918455 035 $a(Perlego)2758618 035 $a(EXLCZ)991000000000688126 100 $a19800221d1980 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDrug concentrations in neuropsychiatry 205 $a1st ed. 210 $aAmsterdam ;$aNew York $cExcerpta Medica ;$aNew York, N.Y. $cElsevier/North-Holland$d1980 215 $a1 online resource (192 p.) 225 1 $aCiba Foundation symposium (new series) ;$v74 300 $a"Symposium on Drug Concentrations in Neuropsychiatry, held at the Ciba Foundation, London, 4th-5th July 1979"--Participants page. 311 08$a9780470663851 311 08$a0470663855 311 08$a9780444901378 311 08$a044490137X 320 $aIncludes bibliographical references and indexes. 327 $aIntro -- Drug Concentrations in Neuropsychiatry -- Contents -- Introduction: The rational use of plasma drug levels in clinical medicine -- Discussion -- Principles of pharmacokinetics -- Discussion -- Methodological pitfalls: the influence of experimental design on results -- Discussion -- Interpretation of drug levels: relevance of plasma binding -- Discussion -- Quality control of drug assays -- Discussion -- Lithium concentrations and clinical responses -- Discussion -- Blood levels of flupenthixol in patients with acute and chronic schizophrenia -- Discussion -- Clinical significance of monitoring plasma levels of psychotropic drugs -- Discussion -- Benzodiazepines: some aspects of their clinical pharmacology -- Discussion -- Adrenergic and serotonergic mechanisms in depression and their response to amitriptyline -- Discussion -- The role of plasma level monitoring of tricyclic antidepressant drugs as an aid to treatment -- Discussion -- Clinical application of the monitoring of anticonvulsant drug levels -- Discussion -- The logistics of drug monitoring -- Discussion -- Alternative approaches -- Discussion -- GENERAL DISCUSSION -- Statistics and experimental design -- Further research on drug levels -- A guide for the doctor -- Concluding remarks -- Appendix Monitoring plasma concentrations of psychotropic drugs as an aid to treatment -- Index of contributors -- Subject index. 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aCiba Foundation symposium ;$vnew ser. 74. 606 $aNeuropsychopharmacology$vCongresses 606 $aPsychotropic drugs$vCongresses 615 0$aNeuropsychopharmacology 615 0$aPsychotropic drugs 676 $a616.89/18 712 02$aCiba Foundation. 712 12$aSymposium on Drug Concentrations in Neuropsychiatry 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818860903321 996 $aDrug concentrations in neuropsychiatry$91963084 997 $aUNINA